Sue A. Ingles
University of Southern California
224 Papers
2.5K Citations
Sue A. Ingles is an academic researcher from University of Southern California. The author has contributed to research in topics: Prostate cancer & Population. The author has an hindex of 64, co-authored 204 publications. Previous affiliations of Sue A. Ingles include University of California, Los Angeles & Quest Diagnostics.
Chat about Author
Papers
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher,Ali Amin Al Olama,Sonja I. Berndt,Sara Benlloch,Mahbubl Ahmed,Edward J. Saunders,Tokhir Dadaev,Daniel Leongamornlert,Ezequiel Anokian,Clara Cieza-Borrella,Chee Goh,Mark N. Brook,Xin Sheng,Laura Fachal,Joe Dennis,Jonathan Tyrer,Kenneth Muir,Kenneth Muir,Artitaya Lophatananon,Artitaya Lophatananon,Victoria L. Stevens,Susan M. Gapstur,Brian D. Carter,Catherine M. Tangen,Phyllis J. Goodman,Ian M. Thompson,Jyotsna Batra,Jyotsna Batra,Suzanne K. Chambers,Suzanne K. Chambers,Leire Moya,Leire Moya,Judith A. Clements,Judith A. Clements,Lisa G. Horvath,Wayne D. Tilley,Gail P. Risbridger,Gail P. Risbridger,Henrik Grönberg,Markus Aly,Tobias Nordström,Paul D.P. Pharoah,Nora Pashayan,Johanna Schleutker,Teuvo L.J. Tammela,Csilla Sipeky,Anssi Auvinen,Demetrius Albanes,Stephanie J. Weinstein,Alicja Wolk,Alicja Wolk,Niclas Håkansson,Catharine M L West,Alison M. Dunning,Neil G. Burnet,Lorelei A. Mucci,Edward Giovannucci,Gerald L. Andriole,Olivier Cussenot,Geraldine Cancel-Tassin,Stella Koutros,Laura E. Beane Freeman,Karina Dalsgaard Sørensen,Torben F. Ørntoft,Michael Borre,Lovise Maehle,Eli Marie Grindedal,David E. Neal,David E. Neal,David E. Neal,Jenny L Donovan,Freddie C. Hamdy,Richard M. Martin,Ruth C. Travis,Timothy J. Key,Robert J. Hamilton,Neil E. Fleshner,Antonio Finelli,Sue A. Ingles,Mariana C. Stern,Barry S. Rosenstein,Sarah L. Kerns,Harry Ostrer,Yong-Jie Lu,Hongwei Zhang,Ninghan Feng,Xueying Mao,Xin Guo,Guomin Wang,Zan Sun,Graham G. Giles,Melissa C. Southey,Robert J. MacInnis,Robert J. MacInnis,Liesel M. FitzGerald,Liesel M. FitzGerald,Adam S. Kibel,Bettina F. Drake,Ana Vega,Antonio Gómez-Caamaño,Robert Szulkin,Martin Eklund,Manolis Kogevinas,Javier Llorca,Gemma Castaño-Vinyals,Kathryn L. Penney,Meir J. Stampfer,Jong Y. Park,Thomas A. Sellers,Hui Yi Lin,Janet L. Stanford,Janet L. Stanford,Cezary Cybulski,Dominika Wokołorczyk,Jan Lubinski,Elaine A. Ostrander,Milan S. Geybels,Børge G. Nordestgaard,Sune F. Nielsen,Maren Weischer,Rasmus Bisbjerg,Martin Andreas Røder,Peter Iversen,Hermann Brenner,Katarina Cuk,Bernd Holleczek,Christiane Maier,Manuel Luedeke,Thomas J. Schnoeller,Jeri Kim,Christopher J. Logothetis,Esther M. John,Esther M. John,Manuel R. Teixeira,Manuel R. Teixeira,Paula Paulo,Marta Cardoso,Susan L. Neuhausen,Linda Steele,Yuan Chun Ding,Kim De Ruyck,Gert De Meerleer,Piet Ost,Azad Hassan Abdul Razack,Jasmine Lim,Soo Hwang Teo,Daniel W. Lin,Daniel W. Lin,Lisa F. Newcomb,Lisa F. Newcomb,Davor Lessel,Marija Gamulin,Tomislav Kuliš,Radka Kaneva,Nawaid Usmani,Nawaid Usmani,Sandeep Singhal,Sandeep Singhal,Chavdar Slavov,Vanio Mitev,Matthew Parliament,Matthew Parliament,Frank Claessens,Steven Joniau,Thomas Van den Broeck,Samantha E.T. Larkin,Paul A. Townsend,Claire Aukim-Hastie,Manuela Gago Dominguez,Jose Esteban Castelao,Maria Elena Martinez,Monique J. Roobol,Guido Jenster,Ron H.N. van Schaik,Florence Menegaux,Thérèse Truong,Yves Akoli Koudou,Jianfeng Xu,Kay-Tee Khaw,Lisa A. Cannon-Albright,Lisa A. Cannon-Albright,Hardev Pandha,Agnieszka Michael,Stephen N. Thibodeau,Shannon K. McDonnell,Daniel J. Schaid,Sara Lindström,Constance Turman,Jing Ma,David J. Hunter,Elio Riboli,A. Siddiq,Federico Canzian,Laurence N. Kolonel,Loic Le Marchand,Robert N. Hoover,Mitchell J. Machiela,Zuxi Cui,Peter Kraft,Christopher I. Amos,David V. Conti,Douglas F. Easton,Fredrik Wiklund,Stephen J. Chanock,Brian E. Henderson,Zsofia Kote-Jarai,Christopher A. Haiman,Rosalind A. Eeles +207 more
TL;DR: A large meta-analysis combining genome-wide and custom high-density genotyping array data identifies 63 new susceptibility loci for prostate cancer, enhancing fine-mapping efforts and providing insights into the underlying biology of PrCa1.
Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans.
Jaime Guevara-Aguirre,Priya Balasubramanian,Marco Guevara-Aguirre,Min Wei,Federica Madia,Chia-Wei Cheng,David Hwang,Alejandro Martin-Montalvo,Alejandro Martin-Montalvo,Jannette Saavedra,Sue A. Ingles,Rafael de Cabo,Pinchas Cohen,Valter D. Longo +13 more
TL;DR: Although it is difficult to prove that alterations in IGF-1 amounts are responsible for the cancer- and diabetes-free lives of these Ecuadorian people, genetic work from several model organisms suggests that this is so, and mutations in growth signaling pathways extend life span and reduce abnormal cellular proliferation in worms.
Multiple regions within 8q24 independently affect risk for prostate cancer.
Christopher A. Haiman,Nick Patterson,Matthew L. Freedman,Matthew L. Freedman,Simon Myers,Malcolm C. Pike,Alicja Waliszewska,Alicja Waliszewska,Alicja Waliszewska,Julie Neubauer,Julie Neubauer,Arti Tandon,Arti Tandon,Christine Schirmer,Christine Schirmer,Gavin J. McDonald,Gavin J. McDonald,Steven C. Greenway,Daniel O. Stram,Loic Le Marchand,Laurence N. Kolonel,Melissa A. Frasco,David T.W. Wong,Loreall Pooler,Kristin G. Ardlie,Ingrid Oakley-Girvan,Alice S. Whittemore,Kathleen A. Cooney,Esther M. John,Sue A. Ingles,David Altshuler,Brian E. Henderson,David Reich,David Reich +33 more
TL;DR: Seven prostate cancer risk variants are identified, five of them previously undescribed, spanning 430 kb and each independently predicting risk for prostate cancer (P = 7.9 × 10−19 for the strongest association), and common genotypes that span a more than fivefold range of susceptibility to cancer in some populations are defined.
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men
Matthew L. Freedman,Christopher A. Haiman,Nick Patterson,Gavin J. McDonald,Gavin J. McDonald,Arti Tandon,Arti Tandon,Alicja Waliszewska,Alicja Waliszewska,Kathryn L. Penney,Robert G. Steen,Kristin Ardlie,Esther M. John,Esther M. John,Ingrid Oakley-Girvan,Ingrid Oakley-Girvan,Alice S. Whittemore,Kathleen A. Cooney,Sue A. Ingles,David Altshuler,David Altshuler,Brian E. Henderson,David Reich,David Reich +23 more
TL;DR: Admixture mapping indicates a major, still-unidentified risk gene for prostate cancer at 8q24, motivating intense work to find it and finding that the previously described alleles do not explain more than a fraction of the admixture signal.
656
Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy.
Sheeja T. Pullarkat,Jan Stoehlmacher,V. Ghaderi,Yi Ping Xiong,Sue A. Ingles,Andy Sherrod,Robert S. Warren,Denise D. Tsao-Wei,Susan Groshen,Heinz-Josef Lenz +9 more
TL;DR: The data suggest that genotyping for the TS polymorphism may have the potential to identify patients more likely to respond to 5-FU based chemotherapy, and to predict clinical outcome of patients with metastatic colorectal cancer treated with 5-fluorouracil.
603